precise
Posted - 10 hours ago
$AQST $XBI Historically biotechs will trade significantly higher post rate cut. (Plus for AQST some near term catalysts)
shaveapenny
Posted - 15 hours ago
$AQST Presentations start next week. Investor day is coming (which should include new info on AQST 108). Also, Phase 3 results should release in Q4 for Anaphylm, We then proceed to file for FDA approval date. I predict as NEFFY hits the market, there is room for the AQST’s SP to move up significantly as the epi-pen alternatives makes the national news . Again, NEFFY success will only grow interest for AQST.
Think about it, the entire company value is now equal to the cost of one Boeing 777 300 ER commercial jet.
To compare, American Airlines owns 20 of these jets in therir fleet.
I am convinced the market cap is too low, which means we have a high probability to be bought out before 109 ever reaches approval.
Confirming, I added 12% to my position yesterday.
Outrageous
Posted - 18 hours ago
$AQST it’s happening fellow longs, check this out:
Outrageous
Posted - 18 hours ago
$AQST This is getting interesting. On September 5th Aquestive posted this new job:
Direct to Consumer (DTC) Marketing Director
Job Category: Marketing
https://recruiting.ultipro.com/AQU1000AQUE/JobBoard/8a380b89-3c6f-4511-8697-2fe5c64de6ac/OpportunityDetail?opportunityId=1e7883a2-99eb-40a9-a963-7fe1db975a32
SHADOWxGAINZ
Posted - 1 day ago
$AQST $SPRY lol 😂 😂😂😂😂😂😂 how’s that King treatment going for you mister man?
SHADOWxGAINZ
Posted - 1 day ago
$AQST why it red
nomas
Posted - 1 day ago
$AQST interesting how movement can be tranquil. Like watching the waves roll through. I think we need some tranquility here on the upside.
BiotechPsycho
Posted - 1 day ago
$AQST Closed right above the SMA20.
h8ster
Posted - 1 day ago
$AQST Not bad for the shortened week considering it was one of the worst market weeks over the last year. Closed last week at $4.53, ended this week at $4.18. Down $0.35, or around mid -7% ish. And, the good news out of it all, is our daily RSI has been reset to the mid 50's. We are still up 23% over the last month and are no longer considered overbought. We held the $4's as we move into next week with 2 major conferences. I don't expect much from the conferences in terms of price action. They rarely provide any volume. Why? They say nothing new. They just repeat already known info. But they are telling it to new people. The main purpose of these things is create awareness. To get it on the radar of new, bigger than average market players, with the hopes they will eventually. make some purchases. These sell days are opportunities to buy the dip for those accumulating. Given the volatility of September, its best to accumulate in small blocks
Falcones
Posted - 1 day ago
$AQST Considering markets this is holding pretty strong! Can’t wait for upcoming catalysts. It’s going to be a wild ride and everyday management is getting closer to getting Anaphylm to the finishline.🚀
prototyper
Posted - 1 day ago
$AQST Better than ETFs
InnerVoice
Posted - 1 day ago
$AQST Bought more down here because i think we will be over 5 by end of month.
n44
Posted - 1 day ago
$AQST The stock price is definitely holding up well for a Friday and the September bad news month for the stock market. I am hopeful we get a bunch of good news starting Monday.
nomas
Posted - 1 day ago
$AQST f-ing macro bs. buying.
Lilwopjob
Posted - 1 day ago
$IOVA $AQST Ugh, I’m not worried. I am bored.
Optimisticinvestor777
Posted - 1 day ago
$AQST
TIG2
Posted - 1 day ago
$AQST From a Spry vs Aqst it's looking like Aqst is starting to show the upper hand...IMHO just watching the share price of both...
Acemaker12
Posted - 1 day ago
$AQST If I were AQST, when ANAPHYLM™* gets approved, I would do direct side by side comparisons vs neffy in its promotions.
ronnie3369
Posted - 1 day ago
$AQST ...Now that the U.S. Payroll Data is Out and Actually Came in Lower than Expected...Maybe .50 Cut Instead of .25.....
Stone52
Posted - 1 day ago
$AQST last trading day before Monday’s 8:30am east coast time presentation.
shaveapenny
Posted - 1 day ago
$AQST ‘If you go below $4, I buy more”
You guys didn’t know Batman was a poet!
RoyMunson69
Posted - 2 days ago
$AQST Looking forward to the analverse platform.
n44
Posted - 2 days ago
$AQST Obviously there is little or no volume, everyone is waiting for the conference on Monday. There should be a blast of newsworthy events coming this month, holding onto our shares for big gains.
prototyper
Posted - 2 days ago
$AQST Seems calm before the storm.
h8ster
Posted - 2 days ago
$AQST Can't remember the last time volume was this low. Forcing sellers to market sell the bid. LMAOF
RCaptain
Posted - 2 days ago
$AQST Where's our little bid dumper? Here fishy fishy.
ronnie3369
Posted - 2 days ago
$AQST ...Volume is Pathetic Today....I has to Check and See if this was Halted...lol
fda_tracker
Posted - 2 days ago
$AQST Phase 2 trial w/est Sep completion date NCT06527937: https://www.clinicaltrials.gov/study/NCT06527937 Trial Tracker: https://www.fdatracker.com/trial-tracker/
Outrageous
Posted - 2 days ago
$AQST Are they ready for the Adrenavers Platform? Lotions, Creams, and Ointment Manufacturing Aquestive has solution mixing experience focused on the production of both pharmaceutical and over-the-counter products for a variety of vendors. With different mix platforms and different sized mix tanks from 12 gallons to 500 liters, we can seamlessly manufacture products from pilot scale to commercial scale. Our expertise in mixing products enables us to maintain the homogeneity of all ingredients throughout the mixing process. Beginning with analytical and formulation development, our team’s experts complete all phases of production within our FDA-approved facilities, while following the strictest FDA requirements to achieve the desired therapeutic effect. https://aquestive.com/services/